Benshang Li

1.5k total citations
33 papers, 450 citations indexed

About

Benshang Li is a scholar working on Molecular Biology, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Benshang Li has authored 33 papers receiving a total of 450 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 12 papers in Oncology and 10 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Benshang Li's work include Acute Lymphoblastic Leukemia research (10 papers), CAR-T cell therapy research (9 papers) and Acute Myeloid Leukemia Research (5 papers). Benshang Li is often cited by papers focused on Acute Lymphoblastic Leukemia research (10 papers), CAR-T cell therapy research (9 papers) and Acute Myeloid Leukemia Research (5 papers). Benshang Li collaborates with scholars based in China, United States and United Kingdom. Benshang Li's co-authors include Shuhong Shen, Yu Liu, Jinghui Zhang, Lixia Ding, Yongjin Li, Diane A. Flasch, Liqing Tian, Shawn Levy, Joy Nakitandwe and Xiaotu Ma and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Benshang Li

29 papers receiving 444 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Benshang Li China 11 271 93 90 70 66 33 450
Dragana Vujić Serbia 11 271 1.0× 61 0.7× 100 1.1× 45 0.6× 33 0.5× 43 450
Christelle Pérez France 10 126 0.5× 61 0.7× 63 0.7× 59 0.8× 82 1.2× 14 384
Stéphane Avner France 11 500 1.8× 66 0.7× 58 0.6× 121 1.7× 33 0.5× 24 633
Yang Jo Chung United States 12 344 1.3× 62 0.7× 53 0.6× 26 0.4× 174 2.6× 30 518
Veronika I. Zabarovska Sweden 13 508 1.9× 146 1.6× 98 1.1× 88 1.3× 27 0.4× 19 635
José Antonio Casado Spain 14 355 1.3× 98 1.1× 79 0.9× 123 1.8× 70 1.1× 25 464
Luc‐Marie Gerland France 6 185 0.7× 47 0.5× 45 0.5× 35 0.5× 26 0.4× 11 443
Kieran O’Neill Canada 14 408 1.5× 74 0.8× 25 0.3× 68 1.0× 48 0.7× 28 576
Shida Zhu China 13 276 1.0× 162 1.7× 99 1.1× 70 1.0× 12 0.2× 37 484
David J. Young United States 16 556 2.1× 34 0.4× 55 0.6× 118 1.7× 226 3.4× 35 835

Countries citing papers authored by Benshang Li

Since Specialization
Citations

This map shows the geographic impact of Benshang Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benshang Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benshang Li more than expected).

Fields of papers citing papers by Benshang Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benshang Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benshang Li. The network helps show where Benshang Li may publish in the future.

Co-authorship network of co-authors of Benshang Li

This figure shows the co-authorship network connecting the top 25 collaborators of Benshang Li. A scholar is included among the top collaborators of Benshang Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Benshang Li. Benshang Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Yandi, Jiaoyang Cai, Tianyi Wang, et al.. (2024). Glycoprotein 350-targeted chimeric antigen receptor T-cell therapy for nonneoplastic chronic active Epstein-Barr virus infection: a case report. Translational Pediatrics. 13(12). 2305–2310.
2.
Su, Meng, Lihua Xie, Aurore Fleurie, et al.. (2024). Identification of early predictive biomarkers for severe cytokine release syndrome in pediatric patients with chimeric antigen receptor T-cell therapy. Frontiers in Immunology. 15. 1450173–1450173. 8 indexed citations
3.
Yin, Xuedong, et al.. (2024). CDKN1A promotes Cis-induced AKI by inducing cytoplasmic ROS production and ferroptosis. Food and Chemical Toxicology. 193. 115003–115003. 4 indexed citations
4.
5.
Yang, Xiaomin, Xiaohang Huang, Jian Zhang, et al.. (2023). Case Report: Unedited allogeneic chimeric antigen receptor T cell bridging to conditioning-free hematopoietic stem cell transplantation for a child with refractory Burkitt lymphoma. Frontiers in Immunology. 14. 1219872–1219872. 2 indexed citations
7.
Wang, Tianyi, Mingxuan Feng, Xinyu Wan, et al.. (2021). Successful Treatment of Pediatric Refractory Burkitt Lymphoma PTLD after Liver Transplantation using Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy. Cell Transplantation. 30. 2139989353–2139989353. 19 indexed citations
8.
Wan, Xinyu, Xiaomin Yang, Fan Yang, et al.. (2021). Outcomes of Anti-CD19 CAR-T Treatment of Pediatric B-ALL with Bone Marrow and Extramedullary Relapse. Cancer Research and Treatment. 54(3). 917–925. 10 indexed citations
9.
Li, Benshang, Fei Tan, Juan Shen, et al.. (2021). Determination of COL1A1–PDGFB breakpoints by next-generation sequencing in the molecular diagnosis of dermatofibrosarcoma protuberans. Experimental and Molecular Pathology. 122. 104672–104672. 5 indexed citations
10.
Song, Lili, Bo Yu, Yi Yang, et al.. (2020). Identification of functional cooperative mutations of GNAO1 in human acute lymphoblastic leukemia. Blood. 137(9). 1181–1191. 18 indexed citations
12.
Ma, Xiaotu, Ying Shao, Liqing Tian, et al.. (2019). Analysis of error profiles in deep next-generation sequencing data. Genome biology. 20(1). 50–50. 169 indexed citations
13.
Liu, Yang, Lixia Ding, Jianwei Liang, et al.. (2018). Relatively favorable prognosis for MLL‐rearranged childhood acute leukemia with reciprocal translocations. Pediatric Blood & Cancer. 65(10). e27266–e27266. 4 indexed citations
14.
Li, Niu, et al.. (2018). Functional analysis of Fanconi anemia mutations in China. Experimental Hematology. 66. 32–41.e8. 14 indexed citations
15.
Shen, Shuhong, Jiaoyang Cai, Jing Chen, et al.. (2018). Long‐term results of the risk‐stratified treatment of childhood acute lymphoblastic leukemia in China. Hematological Oncology. 36(4). 679–688. 22 indexed citations
16.
Li, Qian, et al.. (2017). Disease-specific hematopoietic stem cell transplantation in children with inherited bone marrow failure syndromes. Annals of Hematology. 96(8). 1389–1397. 13 indexed citations
17.
Abraham, Brian J., Denes Hnisz, Abraham S. Weintraub, et al.. (2017). Small genomic insertions form enhancers that misregulate oncogenes. Nature Communications. 8(1). 14385–14385. 62 indexed citations
18.
He, Yingyi, Benshang Li, Jing Chen, et al.. (2011). Asparagine synthetase is partially localized to the plasma membrane and upregulated by L-asparaginase in U937 cells. Journal of Huazhong University of Science and Technology [Medical Sciences]. 31(2). 159–163. 4 indexed citations
19.
Xiong, Hui, Kun Xia, Benshang Li, Guoping Zhao, & Zhuohua Zhang. (2009). KChIP1: a potential modulator to GABAergic system. Acta Biochimica et Biophysica Sinica. 41(4). 295–300. 18 indexed citations
20.
Gu, Long-Jun, et al.. (2008). Comparative proteomic analysis of differentially expressed proteins between K562 and K562/ADM cells. Chinese Medical Journal. 121(5). 463–468. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026